Hims & Hers Health, Inc. (HIMS) Reports In-Line Q3 EPS, provides guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $226.7 million versus the consensus estimate of $220.08 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2023 revenue of $868-873 million, versus the consensus of $846.7 million. And Adjusted EBITDA guidance to a range of $43 million to $46 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Sherwin-Williams climbs 18% off 52-week low as Citi sets $380 target
• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations